CompletedNot Applicable

Thromboelastography in Non-elective Cesarean Delivery

United States33 participantsStarted 2011-08

Plain-language summary

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Obstetric in-patients * Laboring patients with Epidurals for Labor Analgesia going for non-elective Cesarean * Patients of all ethnic backgrounds will be included * Singleton pregnancy * ASA 1 or 2 Exclusion Criteria: * Patients with underlying coagulation disorders. * Patients with thrombocytopenia (platelet count \<100). * Patients with pregnancy-induced hypertension, pre-eclampsia. * Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants. * Patients requiring elective Cesarean delivery. * Patients with significant obstetric or medical disease. * No patients \<18 years of age will be recruited.

What they're measuring

Estimated blood loss; Coagulation data (Thromboelastography, Laboratory)

Timeframe: pre and post cesarean delivery, an expected average of 75 minutes

Trial details

NCT IDNCT01514591

SponsorStanford University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-06

View on ClinicalTrials.gov More Bleeding trials